Home/ Stocks/ DARE

Dare Bioscience, Inc. Common Stock

DARE XNAS

$1.40 +0.08 (+6.02%) ▲ 15-min delayed

Open

$1.36

High

$1.42

Low

$1.36

Volume

91.8K

Market Cap

$19.92M

About Dare Bioscience, Inc. Common Stock

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 24 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$152.5K	$-2,999,889	$-0.21
FY 2025	$1.03M	$-13,399,274	$-1.20
Q3 2025	$2.3K	$-3,562,766	$-0.28
Q2 2025	$-21,172	$-4,016,483	$-0.45

Related Market News

No specific coverage for DARE yet. Check out our latest market news or earnings calendar.

Get DARE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Dare Bioscience, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.